SCM

Squadron Capital Management Portfolio holdings

AUM $250M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$250M
AUM Growth
+$25.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$9.38M
2
+$8.46M
3
+$8.4M
4
NKTR icon
Nektar Therapeutics
NKTR
+$7.12M
5
RLAY icon
Relay Therapeutics
RLAY
+$6.02M

Top Sells

1
+$10.3M
2
+$7.68M
3
+$6.55M
4
UPB
Upstream Bio Inc
UPB
+$6.26M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$4.73M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLMD icon
1
Relmada Therapeutics
RLMD
$726M
$59M 23.6%
8,474,571
+1,774,571
COGT icon
2
Cogent Biosciences
COGT
$5.67B
$30.3M 12.13%
787,492
+7,492
KALV icon
3
KalVista Pharmaceuticals
KALV
$1.43B
$19.8M 7.93%
985,100
+285,100
KOD icon
4
Kodiak Sciences
KOD
$2.28B
$14.5M 5.8%
380,000
+88,290
ABVX
5
Abivax
ABVX
$10.1B
$14.5M 5.79%
130,000
-15,000
EWTX icon
6
Edgewise Therapeutics
EWTX
$3.44B
$11M 4.41%
350,000
NKTR icon
7
Nektar Therapeutics
NKTR
$2.25B
$8.99M 3.6%
+125,000
ANL
8
Adlai Nortye
ANL
$782M
$8.76M 3.5%
+1,265,231
ZNTL icon
9
Zentalis Pharmaceuticals
ZNTL
$285M
$8.5M 3.4%
+3,631,000
MAZE
10
Maze Therapeutics
MAZE
$1.44B
$7.69M 3.08%
257,500
-232,500
SCYX icon
11
SCYNEXIS
SCYX
$55.1M
$6.98M 2.79%
+7,608,695
RLAY icon
12
Relay Therapeutics
RLAY
$2.94B
$6.69M 2.68%
+672,500
CCCC icon
13
C4 Therapeutics
CCCC
$398M
$5.92M 2.37%
+2,250,000
IKT icon
14
Inhibikase Therapeutics
IKT
$227M
$5.88M 2.35%
3,500,000
-725,000
PALI icon
15
Palisade Bio
PALI
$344M
$5.25M 2.1%
3,000,000
-1,500,000
EPRX
16
Eupraxia Pharmaceuticals
EPRX
$485M
$4.92M 1.97%
680,000
+180,000
GHRS icon
17
GH Research
GHRS
$1.5B
$4.57M 1.83%
325,000
+10,000
PMN icon
18
ProMIS Neurosciences
PMN
$96.8M
$4.13M 1.65%
+324,977
LPCN icon
19
Lipocine
LPCN
$19M
$3.6M 1.44%
450,000
-80,000
IVA
20
Inventiva
IVA
$1.07B
$2.97M 1.19%
535,000
+235,000
ALXO icon
21
ALX Oncology
ALXO
$261M
$2.93M 1.17%
+1,460,000
CNTX icon
22
Context Therapeutics
CNTX
$235M
$2.88M 1.15%
+1,100,000
NXTC icon
23
NextCure
NXTC
$24.2M
$2.83M 1.13%
265,000
+28,034
SLGL icon
24
Sol-Gel Technologies
SLGL
$262M
$2.46M 0.98%
+31,000
KTTA icon
25
Pasithea Therapeutics
KTTA
$23.3M
$1.56M 0.62%
2,100,000
1
2